Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MicroVision, Inc. (NASDAQ: MVIS) SEC filings, offering a centralized view of the company’s regulatory disclosures. Through these documents, investors can review how MicroVision reports on its lidar hardware and perception software business, its activities in automotive, industrial, and defense-related markets, and its corporate governance and financing arrangements.
Key filings for MicroVision include Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s business, risk factors, and financial results. These reports are particularly relevant for understanding MicroVision’s investment in solid-state lidar technologies, its focus on ADAS and autonomous driving, and its efforts in industrial automation and defense tech. Current reports on Form 8-K provide timely updates on material events, such as leadership changes, executive compensation arrangements, board appointments, and the announcement of quarterly results.
MicroVision’s filings also document corporate actions like the appointment of a new Chief Executive Officer, the designation of an Executive Vice Chair, changes in board composition, and transitions in the Chief Financial Officer role. These disclosures help investors track how the company’s leadership and governance structure evolve alongside its strategic focus on autonomy and mobility.
On Stock Titan, MicroVision’s SEC documents are updated in near real time as they are posted to EDGAR. AI-powered summaries assist readers by highlighting the main points in lengthy filings, including key business updates, segment information where provided, and notable risk or governance items. Users can quickly scan 10-K and 10-Q reports, review 8-K announcements about material events, and access other filings while relying on AI-generated explanations to navigate complex regulatory language more efficiently.
MicroVision, Inc. CEO Glen W. DeVos reported an acquisition of company stock. On March 15, 2026, he acquired 187,900 shares of MicroVision common stock directly from the company at $0.5322 per share under a Subscription Agreement, matching the March 13, 2026 closing price.
Following this transaction, DeVos directly holds 187,900 shares. A footnote states the purchase is intended to be an exempt transaction pursuant to Rule 16b-3.
MicroVision director Jada Smith acquired 28,185 shares of common stock directly from the company in a subscription transaction. The shares were purchased at $0.5322 per share, matching the closing price of MicroVision stock on March 13, 2026.
After this grant/award acquisition, Smith directly owns 154,543 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions with the issuer.
MicroVision, Inc. general counsel Drew G. Markham acquired 9,395 shares of common stock directly from the company on March 15, 2026. The purchase price was $0.5322 per share, matching the closing price on March 13, 2026 as set by a subscription agreement.
Following this transaction, Markham directly holds 388,329 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which generally covers certain insider transactions approved under specific governance procedures.
MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company. The shares were purchased at $0.5322 per share, matching the closing price on March 13, 2026, under a Subscription Agreement executed on March 15, 2026.
After this acquisition, Hrynewich directly holds 172,092 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions for reporting and short-swing profit purposes.
MicroVision, Inc. reported that all of its executive officers and U.S.-based board members have committed to purchase shares of the company’s common stock directly from the company. Pursuant to subscription agreements signed March 15, 2026, they will buy an aggregate of $310,000 of stock at $0.5322 per share, matching Friday’s Nasdaq closing price.
Because of regulatory considerations, these insider purchases are structured as direct issuances by MicroVision rather than open‑market buys, so the full proceeds go to the company. The purchased shares will be restricted, and the participating directors and executives will hold them until they cease to be affiliates, aligning their financial exposure with the company’s long‑term performance.
MICROVISION, INC. interim CFO Stephen Hrynewich reported equity compensation activity and related tax withholding. On March 5, 2026, 4,800 restricted stock units vested and converted on a unit-for-share basis into 4,800 shares of common stock at no cash cost to him.
These shares increased his directly held common stock to 164,256 shares. On March 6, 2026, 1,559 of those shares were disposed of through a withholding, nondiscretionary sell-to-cover transaction completed by the company to satisfy tax obligations, leaving him with 162,697 directly owned shares.
MicroVision, Inc. describes a lidar-focused business that remains in heavy investment mode, with substantial losses and a need for ongoing external funding. As of December 31, 2025, the company had an accumulated deficit of $957.3 million and recorded a $95.0 million net loss for 2025.
Results were hit by non-cash charges, including a $10.1 million impairment of perception software from the Ibeo acquisition, a $9.9 million MOVIA L inventory write-down, $2.2 million machinery impairment, and a $3.2 million adverse purchase commitment. Revenue remains concentrated in a few automotive and industrial customers and has recently declined with lost business.
The company is expanding its lidar portfolio through acquisitions of Ibeo assets in 2023 and, in 2026, Scantinel Photonics and Luminar’s worldwide lidar business, adding IRIS and HALO sensors and FMCW technology. This strategy increases operating costs and integration risk while MicroVision relies on securities purchase agreements and senior secured convertible notes to fund operations.
MicroVision warns it expects significant losses and negative cash flow through at least 2026 and will require additional capital beyond the next 12 months. It also discloses a Nasdaq minimum bid-price deficiency, potential dilution from convertible notes and equity issuance, and the risk of secured lenders foreclosing on its bank and securities accounts if it defaults.
MicroVision, Inc. reported fourth quarter and full year 2025 results showing a small revenue base and sizable losses as it transitions from R&D to commercial operations. Revenue was $223,000 for Q4 2025 and $1.2 million for the year, while net loss reached $37.8 million in Q4 and $95.0 million for 2025.
The company recorded significant non-cash charges, including a Q4 impairment loss on intangible assets of $10.1 million, plus impairments on lease right-of-use assets and property and equipment. Operating cash outflow for 2025 was $58.7 million, and cash, cash equivalents and restricted cash declined to $34.1 million as of December 31, 2025.
Management highlighted a strategic shift in early 2026, completing acquisitions of Luminar and Scantinel and beginning shipments on repeatable orders. To strengthen liquidity, MicroVision issued senior secured convertible notes with aggregate principal of $43.0 million, partly exchanging an existing note due March 2026, and retained access to an additional $43.0 million under an at-the-market equity facility.
MICROVISION, INC. director Robert Paul Carlile reported the vesting and conversion of restricted stock units into common shares. On this date, 22,007 RSUs were exercised at no cost and settled into 22,007 shares of common stock, bringing his directly held common stock to 350,799 shares.
The footnotes explain that RSUs convert into common stock on a unit-for-share basis without payment and clarify that a prior Form 4 understated the original RSU grant, with vesting now calculated from the corrected 88,028-unit grant.
MICROVISION, INC. director Laura J. Peterson reported the vesting of restricted stock units and their conversion into common shares. On March 2, 2026, 18,005 restricted stock units were exercised on a unit-for-share basis without payment, converting into 18,005 shares of common stock. After this conversion, Peterson directly owned 54,016 shares of MICROVISION common stock. The footnotes explain that RSUs convert into shares without cash outlay at vesting and that a separate RSU grant dated July 22, 2025 is scheduled to vest in four equal quarterly installments, subject to her continued board service.